Transforming Ideas into
Innovative Chemical Solutions

“It started with a conviction — that India could build world-class pharmaceutical chemistry capabilities. Dr. Ravindra Pal and Mr. Ankush Sarde founded Sparge Chem in a modest 2000 sq. ft. facility at Bhosari MIDC, Pune. The mission was simple: deliver research-grade pharmaceutical compounds with the precision scientists deserve.”

“Three years in, Sparge Chem was gaining momentum. The team began scaling synthesis programs — 250 building blocks synthesized, process routes developed for key API intermediates. Academic collaborations with leading institutes strengthened the science. This was chemistry with purpose.”

“The turning point. Strategic partnerships opened new doors — 550 building blocks, process development for quinoline derivatives, and a landmark achievement: scaling Letermovir intermediates to 600 kg in GMP and 50kg Non-GMP facilities (99.5+ purity). Sparge Chem had earned its place in the global supply chain.”

“Growth demanded space, and Sparge Chem delivered. A 5000 sq. ft. expanded laboratory, 900 new building blocks, overseas collaborations initiated. Process development for Zavegepant intermediate, Bemnifosbuvir added another breakthrough API to the portfolio. The team was ready for global scale.”

“Today, Sparge Chem stands at the frontier of CRO/CDMO Organization. 1000+ building blocks and API intermediates synthesized. Pilot units of 100L, 250L and 500L operational. The story is far from over — it's accelerating.”